This finale in the first Zelta Podcast series follows up on an article published on 8 January on Pharmaceutical-Technology.com and ClinicalTrialsArena.com, titled ‘Clinical trial trends in 2025: Investment headwinds, wearables, and targeted AI uses’.
The article examined the financial challenges facing clinical trials, which have created a more risk-averse landscape. It explored the digital solutions that could be key for sponsors and CROs to optimize budgets and resources, as well as the trends to watch out for in 2025.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The interviewee for that article was Jennifer Duff, Executive Vice President and General Manager of Zelta by Merative Clinical Trials Solutions. Jennifer is the guest for this episode, where we revisit the original predictions to see how accurate they were and if there were any surprises.
Listen to the episode below:
To catch up on the four previous episodes in the series, listen below:
